> The FDA has accepted Eisai's supplemental NDA for Aricept as a treatment for severe Alzheimer's. Release
> The FDA has granted Nektar Therapeutics orphan drug status for an inhaler treatment used to prevent infections in the lungs of patients with suppressed immune systems. Report
> Chelsea Therapeutics has completed a private placement, raising $21.5 million. Release
> EU health officials are urging calm as the H5N1 virus continues to spread. Slovenia is testing for the virus in dead birds and Nigeria is now testing what may be the first human cases found in Africa. Article
> Immtech International has licensed a new class of anti-infectives--including one for malaria--from Tulane University. Report
> India's Orchid Chemicals has received regulatory approval for its generic version of Merck's Mefoxin. Report
> Researchers say that estrogen therapy may not help women in their 60s but could be helpful in their 50s. Article
> Denmark's Genmab has licensed angiogenesis targets discovered by Bionomics. Release
And Finally… A patient discusses the hallucinations that can be caused by drugs for Parkinson's. Article